vs

Side-by-side financial comparison of COMPX INTERNATIONAL INC (CIX) and DELCATH SYSTEMS, INC. (DCTH). Click either name above to swap in a different company.

COMPX INTERNATIONAL INC is the larger business by last-quarter revenue ($37.7M vs $20.7M, roughly 1.8× DELCATH SYSTEMS, INC.). COMPX INTERNATIONAL INC runs the higher net margin — 12.4% vs -9.1%, a 21.5% gap on every dollar of revenue. On growth, DELCATH SYSTEMS, INC. posted the faster year-over-year revenue change (37.3% vs -1.9%). COMPX INTERNATIONAL INC produced more free cash flow last quarter ($11.4M vs $7.7M). Over the past eight quarters, DELCATH SYSTEMS, INC.'s revenue compounded faster (157.0% CAGR vs -0.4%).

COMPX International Inc. is a diversified manufacturer of security and control products, including high-performance locking systems, electronic access solutions, ergonomic workstation components, and marine hardware. It primarily serves North American and European markets, catering to commercial, residential, industrial, healthcare, and recreational marine segments.

Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in th...

CIX vs DCTH — Head-to-Head

Bigger by revenue
CIX
CIX
1.8× larger
CIX
$37.7M
$20.7M
DCTH
Growing faster (revenue YoY)
DCTH
DCTH
+39.1% gap
DCTH
37.3%
-1.9%
CIX
Higher net margin
CIX
CIX
21.5% more per $
CIX
12.4%
-9.1%
DCTH
More free cash flow
CIX
CIX
$3.7M more FCF
CIX
$11.4M
$7.7M
DCTH
Faster 2-yr revenue CAGR
DCTH
DCTH
Annualised
DCTH
157.0%
-0.4%
CIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIX
CIX
DCTH
DCTH
Revenue
$37.7M
$20.7M
Net Profit
$4.7M
$-1.9M
Gross Margin
32.1%
85.5%
Operating Margin
15.0%
-10.5%
Net Margin
12.4%
-9.1%
Revenue YoY
-1.9%
37.3%
Net Profit YoY
3.6%
44.2%
EPS (diluted)
$0.38
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIX
CIX
DCTH
DCTH
Q4 25
$37.7M
$20.7M
Q3 25
$40.0M
$20.6M
Q2 25
$40.4M
$24.2M
Q1 25
$40.3M
$19.8M
Q4 24
$38.4M
$15.1M
Q3 24
$33.7M
$11.2M
Q2 24
$35.9M
$7.8M
Q1 24
$38.0M
$3.1M
Net Profit
CIX
CIX
DCTH
DCTH
Q4 25
$4.7M
$-1.9M
Q3 25
$4.2M
$830.0K
Q2 25
$5.5M
$2.7M
Q1 25
$5.1M
$1.1M
Q4 24
$4.5M
$-3.4M
Q3 24
$3.5M
$1.9M
Q2 24
$4.8M
$-13.7M
Q1 24
$3.8M
$-11.1M
Gross Margin
CIX
CIX
DCTH
DCTH
Q4 25
32.1%
85.5%
Q3 25
27.6%
87.2%
Q2 25
31.9%
86.3%
Q1 25
30.2%
85.6%
Q4 24
28.8%
85.9%
Q3 24
28.1%
85.4%
Q2 24
31.1%
80.4%
Q1 24
25.5%
71.2%
Operating Margin
CIX
CIX
DCTH
DCTH
Q4 25
15.0%
-10.5%
Q3 25
11.9%
-1.9%
Q2 25
15.7%
10.7%
Q1 25
14.6%
3.2%
Q4 24
12.7%
20.1%
Q3 24
9.9%
-11.2%
Q2 24
14.2%
-50.4%
Q1 24
9.8%
-327.4%
Net Margin
CIX
CIX
DCTH
DCTH
Q4 25
12.4%
-9.1%
Q3 25
10.6%
4.0%
Q2 25
13.5%
11.2%
Q1 25
12.7%
5.4%
Q4 24
11.7%
-22.5%
Q3 24
10.3%
16.6%
Q2 24
13.5%
-176.9%
Q1 24
9.9%
-354.0%
EPS (diluted)
CIX
CIX
DCTH
DCTH
Q4 25
$0.38
$-0.05
Q3 25
$0.34
$0.02
Q2 25
$0.44
$0.07
Q1 25
$0.42
$0.03
Q4 24
$0.37
$-0.06
Q3 24
$0.28
$0.06
Q2 24
$0.39
$-0.48
Q1 24
$0.31
$-0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIX
CIX
DCTH
DCTH
Cash + ST InvestmentsLiquidity on hand
$54.1M
$43.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$138.6M
$111.2M
Total Assets
$156.2M
$123.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIX
CIX
DCTH
DCTH
Q4 25
$54.1M
$43.5M
Q3 25
$46.3M
$41.8M
Q2 25
$56.2M
$34.4M
Q1 25
$56.1M
$12.8M
Q4 24
$60.8M
$32.4M
Q3 24
$58.8M
$8.3M
Q2 24
$82.1M
$14.8M
Q1 24
$75.6M
$11.8M
Total Debt
CIX
CIX
DCTH
DCTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
$2.0M
Q2 24
$4.5M
Q1 24
$7.4M
Stockholders' Equity
CIX
CIX
DCTH
DCTH
Q4 25
$138.6M
$111.2M
Q3 25
$137.7M
$114.8M
Q2 25
$149.5M
$105.0M
Q1 25
$147.6M
$80.2M
Q4 24
$146.1M
$68.7M
Q3 24
$145.3M
$8.6M
Q2 24
$170.2M
$4.2M
Q1 24
$168.9M
$14.6M
Total Assets
CIX
CIX
DCTH
DCTH
Q4 25
$156.2M
$123.6M
Q3 25
$153.7M
$124.3M
Q2 25
$164.8M
$116.9M
Q1 25
$162.2M
$87.3M
Q4 24
$163.0M
$76.6M
Q3 24
$160.1M
$31.7M
Q2 24
$185.1M
$33.9M
Q1 24
$181.7M
$36.1M
Debt / Equity
CIX
CIX
DCTH
DCTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.23×
Q2 24
1.07×
Q1 24
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIX
CIX
DCTH
DCTH
Operating Cash FlowLast quarter
$12.0M
$8.2M
Free Cash FlowOCF − Capex
$11.4M
$7.7M
FCF MarginFCF / Revenue
30.3%
37.1%
Capex IntensityCapex / Revenue
1.6%
2.7%
Cash ConversionOCF / Net Profit
2.57×
TTM Free Cash FlowTrailing 4 quarters
$19.1M
$21.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIX
CIX
DCTH
DCTH
Q4 25
$12.0M
$8.2M
Q3 25
$6.3M
$4.8M
Q2 25
$4.7M
$7.3M
Q1 25
$-137.0K
$2.2M
Q4 24
$7.3M
$-1.0M
Q3 24
$4.1M
$-3.6M
Q2 24
$9.8M
$-4.5M
Q1 24
$1.7M
$-9.6M
Free Cash Flow
CIX
CIX
DCTH
DCTH
Q4 25
$11.4M
$7.7M
Q3 25
$5.3M
$4.3M
Q2 25
$3.4M
$6.9M
Q1 25
$-959.0K
$2.1M
Q4 24
$7.1M
$-1.2M
Q3 24
$3.6M
$-3.9M
Q2 24
$9.4M
$-4.6M
Q1 24
$1.4M
$-9.6M
FCF Margin
CIX
CIX
DCTH
DCTH
Q4 25
30.3%
37.1%
Q3 25
13.2%
21.0%
Q2 25
8.4%
28.5%
Q1 25
-2.4%
10.4%
Q4 24
18.5%
-8.2%
Q3 24
10.8%
-34.4%
Q2 24
26.2%
-58.6%
Q1 24
3.6%
-305.7%
Capex Intensity
CIX
CIX
DCTH
DCTH
Q4 25
1.6%
2.7%
Q3 25
2.5%
2.2%
Q2 25
3.3%
1.6%
Q1 25
2.0%
0.7%
Q4 24
0.6%
1.5%
Q3 24
1.4%
1.9%
Q2 24
1.2%
1.3%
Q1 24
0.8%
0.4%
Cash Conversion
CIX
CIX
DCTH
DCTH
Q4 25
2.57×
Q3 25
1.48×
5.75×
Q2 25
0.87×
2.70×
Q1 25
-0.03×
2.06×
Q4 24
1.62×
Q3 24
1.18×
-1.95×
Q2 24
2.03×
Q1 24
0.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CIX
CIX

Security Products$29.5M78%
Marine Components$8.2M22%

DCTH
DCTH

HEPZATOKIT$19.1M92%
CHEMOSAT$1.7M8%

Related Comparisons